Annual Report

Overview

The report presents EXACT Therapeutics' 2023 clinical and financial progress, including ACTIVATE trial advancement, a strategic Cordance Medical partnership, and NOK 25 million gross proceeds from a private placement. Its ESG report links the company's activities to SDGs 3, 8, 9, 12 and 17 and describes an initial impact assessment to identify prominent ESG matters. It also reports 12 full-time employees, four women, and no work-related accidents in 2023.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services